BCACU
Brookline Capital Acquisition Corp. [BCACU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BCACU Stock Summary
In the News
BCACU Financial details
Company Rating
-
Market Cap
0
Income
-4M
Revenue
0
Book val./share
-2.75
Cash/share
30.74
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
0.75
P/FCF
-
Quick Ratio
1.16
Current Ratio
1.24
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.24
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
181.82%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-626%
ROE
-3022%
ROC
-10.38%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
-
52W High
-
52W Low
-
RSI
100
Rel Volume
-
Avg Volume
-
Volume
9.93K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
123.51%
-
-
-
-
Beta
0.053908
-
-
Volatility
6.42%, 6.42%
Prev Close
0%
Price
23.2
Change
129.93%
BCACU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2020-12-31 | 2021-12-31 |
|---|---|---|---|
| 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | |
| Net income per share | 0 | -0.05 | |
| Operating cash flow per share | 0 | -0.06 | |
| Free cash flow per share | 0 | -0.06 | |
| Cash per share | 0 | 0 | |
| Book value per share | 0 | 0 | |
| Tangible book value per share | 0 | 0.01 | |
| Share holders equity per share | 0 | 0 | |
| Interest debt per share | 0 | -0.02 | |
| Market cap | 0 | 74.42M | |
| Enterprise value | 72.13K | 74.42M | |
| P/E ratio | 0 | -203.92 | |
| Price to sales ratio | 0 | 0 | |
| POCF ratio | 0 | -164.82 | |
| PFCF ratio | 0 | -164.82 | |
| P/B Ratio | 0 | 15.52M | |
| PTB ratio | 0 | 15.52M | |
| EV to sales | 0 | 0 | |
| Enterprise value over EBITDA | 0 | -153.74 | |
| EV to operating cash flow | 0 | -164.82 | |
| EV to free cash flow | 0 | -164.82 | |
| Earnings yield | 0 | 0 | |
| Free cash flow yield | 0 | -0.01 | |
| Debt to equity | 3.03 | 0 | |
| Debt to assets | 0.75 | 0 | |
| Net debt to EBITDA | 0 | 0 | |
| Current ratio | 0.01 | 1.24 | |
| Interest coverage | 0 | 5.06 | |
| Income quality | 0 | 0.93 | |
| Dividend Yield | 0 | 0 | |
| Payout ratio | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | |
| Capex to revenue | 0 | 0 | |
| Capex to depreciation | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | |
| Graham number | 0 | 0 | |
| ROIC | 0 | -94.82K | |
| Return on tangible assets | 0 | -6.26 | |
| Graham Net | 0 | 0 | |
| Working capital | -72.13K | 44.12 | |
| Tangible asset value | 24.15K | 58.08K | |
| Net current asset value | -72.13K | -5.54 | |
| Invested capital | 3.03 | 0 | |
| Average receivables | 0 | 0 | |
| Average payables | 0 | 11.28 | |
| Average inventory | 0 | 0 | |
| Days sales outstanding | 0 | 0 | |
| Days payables outstanding | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | |
| Receivables turnover | 0 | 0 | |
| Payables turnover | 0 | 0 | |
| Inventory turnover | 0 | 0 | |
| ROE | 0 | -76.09K | |
| Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.05 | 0.19 | -0.17 | -0.33 | -0.93 | |
| Operating cash flow per share | -0.01 | -0.05 | 0 | -0.02 | -0.04 | |
| Free cash flow per share | -0.01 | -0.05 | 0 | -0.02 | -0.04 | |
| Cash per share | 0.05 | 0.16 | 0.13 | 0.01 | 30.74 | |
| Book value per share | 7.8 | 34.54 | 0 | -0.33 | -2.75 | |
| Tangible book value per share | 7.8 | 34.54 | 34.48 | 7.48 | 27.9 | |
| Share holders equity per share | 7.8 | 34.54 | 0 | -0.33 | -2.75 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 73.92M | 16.76M | 16.86M | 74.94M | 17.11M | |
| Enterprise value | 73.57M | 16.49M | 16.64M | 74.85M | 17.04M | |
| P/E ratio | -46.24 | 13.23 | -15 | -7.62 | -2.72 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -1.07K | -215.88 | 0 | -603.92 | -268.26 | |
| PFCF ratio | -1.07K | -215.88 | 0 | -603.92 | -268.26 | |
| P/B Ratio | 1.27 | 0.29 | 3.52K | -30.55 | -3.7 | |
| PTB ratio | 1.27 | 0.29 | 3.52K | -30.55 | -3.7 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -261.28 | 218.73 | -60.14 | -30.45 | -9.57 | |
| EV to operating cash flow | -1.07K | -212.34 | 0 | -603.17 | -267.05 | |
| EV to free cash flow | -1.07K | -212.34 | 0 | -603.17 | -267.05 | |
| Earnings yield | -0.01 | 0.02 | -0.02 | -0.03 | -0.09 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 1.25 | -3.64 | 0.79 | 0.04 | 0.04 | |
| Current ratio | 4.2 | 2.33 | 1.24 | 0.07 | 0.02 | |
| Interest coverage | 0 | 0 | -65.04 | -3.82K | 236.24 | |
| Income quality | 0.24 | -1.03 | 0 | 0.05 | 1 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.07 | 12.09 | 0.1 | 1.57 | 7.6 | |
| ROIC | 0 | -0.01 | -57.69 | 1 | 0.34 | |
| Return on tangible assets | -0.01 | 0.01 | 0 | -0.04 | -0.03 | |
| Graham Net | -0.01 | 0.02 | -0.01 | -0.34 | 27.87 | |
| Working capital | 361.1K | 195.1K | 44.12K | -2.41M | -4.7M | |
| Tangible asset value | 58.11M | 58.19M | 58.08M | 55.62M | 46.99M | |
| Net current asset value | 32.58K | 108.76K | -5.54K | -2.47M | -4.71M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 16.92K | 28.55K | 26.42K | 65.58K | 120.8K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.01 | 0.01 | -58.58 | 1 | 0.34 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
BCACU Frequently Asked Questions
What is Brookline Capital Acquisition Corp. stock symbol ?
Brookline Capital Acquisition Corp. is a US stock and trading under the symbol BCACU
What is Brookline Capital Acquisition Corp. stock quote today ?
Brookline Capital Acquisition Corp. stock price is $23.2 today.
Is Brookline Capital Acquisition Corp. stock public?
Yes, Brookline Capital Acquisition Corp. is a publicly traded company.
Company Profile
- CEO James Jiayuan Tong
- Headquarters US
- IPO Date 2021-01-29
-
Website
https://www.brooklinecapitalacquisitioncorp.com 
Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
